These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16540634)

  • 1. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
    Goetzl MA; Holzbeierlein JM
    Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
    J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can prostate cancer be prevented?
    Klein EA
    Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
    J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.
    Crawford ED; Andriole GL; Marberger M; Rittmaster RS
    Urology; 2010 Mar; 75(3):502-9. PubMed ID: 20035983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK; Ford LG
    Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on chemoprevention for prostate cancer.
    Strope SA; Andriole GL
    Curr Opin Urol; 2010 May; 20(3):194-7. PubMed ID: 20216317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer prevention clinical trials.
    Greenwald P
    J Clin Oncol; 2002 Sep; 20(18 Suppl):14S-22S. PubMed ID: 12235220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of prostate cancer.
    Stephenson AJ; Abouassaly R; Klein EA
    Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The finasteride prostate cancer prevention trial (PCPT)--what have we learned?
    Mellon JK
    Eur J Cancer; 2005 Sep; 41(13):2016-22. PubMed ID: 16061372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
    Reed AB; Parekh DJ
    Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.